Literature DB >> 8389079

Mutations in murine Mx1: effects on localization and antiviral activity.

E A Garber1, D L Hreniuk, L M Scheidel, L H van der Ploeg.   

Abstract

Murine Mx1 is a nuclear localized protein of 631 amino acids with antiviral activity against influenza virus. Fourteen mutations in murine Mx1 were constructed in vitro, expressed in chicken embryo fibroblasts via replication-competent retroviruses, and the effects of the mutations on Mx localization and antiviral activity were assayed. The results suggest that a nuclear location is not sufficient for antiviral activity, that there are intricate structural constrains on the Mx protein for antiviral activity and that multiple domains of the Mx protein are required for the characteristic punctate nuclear Mx distribution. These conclusions are based on the findings showing that: (i) none of the mutants retained antiviral activity; (ii) only a mutant with a Leu to Lys substitution at residue 612 within the nuclear targeting signal retained the characteristic punctate nuclear localization of wildtype Mx1; (iii) diffuse nuclear localization was observed for mutants with substitutions of Pro for Leu at residue 619, 626, or both 619 and 626, and deletions of residues 23 to 95, 159 to 185, 369 to 409, 387 to 440, 522 to 560, or 541 to 596; and (iv) cytoplasmic localization was observed for mutants with carboxy-terminal truncations of 15, 30, or 61 amino acids, or a deletion of residues 610 to 624.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389079     DOI: 10.1006/viro.1993.1312

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.

Authors:  Kadir Turan; Masaki Mibayashi; Kenji Sugiyama; Shoko Saito; Akiko Numajiri; Kyosuke Nagata
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

Review 2.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

3.  Antiviral determinants of rat Mx GTPases map to the carboxy-terminal half.

Authors:  L Johannes; R Kambadur; H Lee-Hellmich; C A Hodgkinson; H Arnheiter; E Meier
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity.

Authors:  A Ponten; C Sick; M Weeber; O Haller; G Kochs
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays.

Authors:  Camilla T O Benfield; Jon W Lyall; Georg Kochs; Laurence S Tiley
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

6.  Low ambient humidity impairs barrier function and innate resistance against influenza infection.

Authors:  Eriko Kudo; Eric Song; Laura J Yockey; Tasfia Rakib; Patrick W Wong; Robert J Homer; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-13       Impact factor: 11.205

7.  Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.

Authors:  Dhiraj Singh; Ekaterina Aladyeva; Shibali Das; Bindu Singh; Ekaterina Esaulova; Amanda Swain; Mushtaq Ahmed; Journey Cole; Chivonne Moodley; Smriti Mehra; Larry Schlesinger; Maxim Artyomov; Shabaana Khader; Deepak Kaushal
Journal:  Res Sq       Date:  2021-07-15

8.  Tick-transmitted thogotovirus gains high virulence by a single MxA escape mutation in the viral nucleoprotein.

Authors:  Jonas Fuchs; Alexander Oschwald; Laura Graf; Georg Kochs
Journal:  PLoS Pathog       Date:  2020-11-16       Impact factor: 6.823

9.  Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.

Authors:  Dhiraj K Singh; Ekaterina Aladyeva; Shibali Das; Bindu Singh; Ekaterina Esaulova; Amanda Swain; Mushtaq Ahmed; Journey Cole; Chivonne Moodley; Smriti Mehra; Larry S Schlesinger; Maxim N Artyomov; Shabaana A Khader; Deepak Kaushal
Journal:  Nat Commun       Date:  2022-02-03       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.